US Patent 12,667,564 — assignment history and current owner

US 12,667,564 · Application 17/536,892

Processes For Preparing Morphinan-6-one Products With Low Levels Of Alpha, Beta-unsaturated Ketone Compounds

Who owns US Patent 12,667,564?

US12667564 ("Processes For Preparing Morphinan-6-one Products With Low Levels Of Alpha, Beta-unsaturated Ketone Compounds") — current assignee: SPECGX LLC. Status: Active, estimated expiration March 2, 2027. 5 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,667,564 is SPECGX LLC. Based on the most recent ownership transfer record (recorded 2024-12-16).

Patent title
Processes For Preparing Morphinan-6-one Products With Low Levels Of Alpha, Beta-unsaturated Ketone Compounds
Application number
17/536,892
Apparent operating assignee
SPECGX LLC
Patent status
Active, estimated expiration March 2, 2027
Recorded assignments
5

Note: a security interest appears active (WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT) with no recorded release. Security interests reflect financing arrangements, not operating ownership.

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Nov 14, 2023Nov 15, 2023Security InterestMALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLCACQUIOM AGENCY SERVICES LLC65595/376
Apr 27, 2006Dec 16, 2024Ownership TransferBUEHLER, HENRY J.; DUMMITT, WILLIAM E.; AUBUCHON, DENNIS C.; MANNINO, ANTHONY; GU, HONGMALLINCKRODT INC.69594/429
Dec 13, 2017Dec 16, 2024Ownership TransferMALLINCKRODT LLCSPECGX LLC69594/490
Jul 31, 2025Jul 31, 2025Security AgreementSPECGX LLCWILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT72313/63
Aug 1, 2025Aug 14, 2025Release of Security InterestACQUIOM AGENCY SERVICES LLCMALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC72324/740

Scrolls sideways on narrow screens

Chain of title

In 2024, BUEHLER, HENRY J.; DUMMITT, WILLIAM E. (+3 more) assigned the patent to MALLINCKRODT INC.. The most recent ownership transfer, recorded in 2024, lists SPECGX LLC as assignee. In 2025, WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 17/536,892 · US 12,667,564

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,667,564, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.